Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities
Net loss	$ (1,376,821)	$ (2,493,777)
Adjustments to reconcile net loss to net cash used in operations:
Amortization expense	46,530	36,741
Lease expense	28,395	16,449
Depreciation expense	3,161
Stock options expense	199,852	460,020
Common stock issued for services		903,380
Changes in operating assets and liabilities:
Prepaid expenses	44,132	9,090
Accounts payable	16,661	15,537
Lease liability	(28,395)	(16,449)
Accrued expenses	87,163	(48,363)
Net cash used in operating activities	(979,322)	(1,117,372)
Cash flows from investing activities
Additions to intellectual property	(113,718)	(147,508)
Additions to other intangible assets	(12,244)
Additions to property, plant and equipment		(869,584)
Net cash used in investing activities	(125,962)	(1,017,092)
Cash flows from financing activities
Proceeds from issuance of common stock	120,000	9,225,000
Investor deposits		100,000
Borrowing from related parties	230,063	60,612
Net cash provided by financing activities	350,063	9,385,612
Effect of exchange rate changes on cash	(9,793)	42
Net change in cash and cash equivalents	(765,014)	7,251,190
Cash and cash equivalents, beginning of period	8,914,107	4,596,556
Cash and cash equivalents, end of period	$ 8,149,093	$ 11,847,746